Search

Search Results

• CO:05:4 | Natural language processing reveals demographic features, comorbidities, and clinical domains to predict treatment longevity of b/tsDMARDs in psoriatic arthritis Antonio Tonutti^1|2, Pierandrea Morandini³, Cosimo Faeti³, Nicoletta Luciano^1|2, Saverio D'Amico³, Victor Savevski³, Carlo Selmi^1|2 | ¹Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; ²Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; ³Artificial Intelligence Unit, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2275

  118

• Primary antiphosholipid syndrome and hyperomocysteinemia: a study of a group of 29 patients

  T. Del Ross, A. Ruffatti, M. Tonello, G. Salmistraro, A. Calligaro, M. Favaro, M. Ciprian, S. Todesco

  283-287

  https://doi.org/10.4081/reumatismo.2006.283

  1142

  Downloads: 1222
• 

  The prevalence and clinical spectrum of post-Covid syndrome in patients with rheumatic diseases: a single-center experience

  S. Batıbay, R. Koçak Ulucaköy, Z. Günendi, F. Göğüş

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1481

  2771

  Downloads: 873

• PO:31:165 | Prevalence and incidence of skin telangectasia and their association with clinical features: analysis of the European Scleroderma Trials and Research cohort Gemma Lepri¹, Lorenzo Tofani², Silvia Bellando Randone¹, Veronica Batani³, Paolo Airò⁴, Patricia Carreira⁵, Joerg Henes⁶, Alexandra Balbir Gurman⁷, Florenzo Iannone⁸, Antonella Marcoccia⁹, Luc Mouthon¹⁰, Branimir Anic¹¹, Carolina De Souza Müller¹², Armine Haroyan¹³, Ana Cristina Cordeiro¹⁴, Serena Guiducci And Eustar Coll¹. | ¹University of Florence, Dept of Experimental and Clinical Medicine, AOU Careggi, Division of Rheumatology Florence Italy; ²University of Florence, Dept of Statistics, Informatics, Applications, Florence, Italy; ³Unit of Immunology, Rheumatology, Allergy and Rare Diseases ^UnIRAR, IRCCS San Raffaele, Milano, Italy; ⁴Scleroderma Unit, UOC Rheumatology and Clinical Immunology, ASST Spedali Civili, Brescia, Italy; ⁵Dept of Rheumatology, 12 de Octubre University Hospital, Madrid, Spain; ⁶Centre for Interdisciplinary Rheumatology, Immunology and autoimmune diseases INDIRA, University Hospital Tuebingen, Tuebingen, Germany; ⁷Rheumatology Institute, Rambam Health Care Campus Haifa Israel; ⁸Dept of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy; ⁹Interdisciplinary Reference Center for Systemic Sclerosis ^CRIIS Sandro Pertini Hospital, Rome, Italy; ¹⁰Dept of Internal Medicine, Cochin Hospital, Paris Cité University, Paris, France; ¹¹Div Clinical Immunology and Rheumatology, Dept Internal Medicine, School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia; ¹²Rheumatology Division, Hospital de Clínicas da Universidade Federal do Parana, Curitiba, Brazil; ¹³Dept of Rheumatology, Yerevan State Medical University of Armenia, Yerevan, Armenia; ¹⁴Servico Reumatologia Hospital Garcia de Orta Almada, Almada, Portugal.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2070

  249

• PO:02:018 | After-SECs: clinical predictors of secukinumab retention in psoriatic arthritis patients with inadequate response to anti-tumor necrosis factor therapy Francesco Cristiano¹, Davide Gaspare Patti¹, Valentina Boni¹, Stefano Di Murro¹, Cesare Gavotti¹, Roberta Masnata¹, Giulia Calabrese², Gerlando Natalello², Giusy Peluso², Augusta Ortolan^1|2, Enrico De Lorenzis^1|2, Maria Antonietta D'Agostino^1|2. | ¹Università Cattolica del Sacro Cuore, Roma, Italy; ²Divisione di Reumatologia ed Immunologia clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2009

  254

• Comorbidities in rheumatoid arthritis: analysis of hospital discharge records

  M. Parodi, L. Bensi, T. Maio, G.S. Mela, M.A. Cimmino

  154-160

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.154

  2320

  Downloads: 1700

• PO:08:113 | Shaping rheumatoid arthritis treatment: clinical and demographic drivers of tsDMARDs versus bDMARDs prescription post-EMA pronouncement on JAK inhibitors - insights from the AMBI-RA study Riccardo Bertola¹, Beatrice Maranini¹, Carlo Garaffoni¹, Maria Pozzuto¹, Anna Laura Riva Cambrino¹, Alessandro Spinelli¹, Letizia Mamprin¹, Federico Agostini¹, Martina Di Nunzio¹, Marcello Govoni¹, Alessandra Bortoluzzi¹, Ettore Silvagni¹ | ¹Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2139

  272

• Therapy of rheumatic polymyalgia: the pathophysiologic management

  M. Cutolo, M. Olivieri, M.E. Secchi, M.A. Cimino

  271-279

  https://doi.org/10.4081/reumatismo.2007.271

  1713

  Downloads: 2257

• The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

  M. Varenna, D. Gatti

  163-171

  https://doi.org/10.4081/reumatismo.2010.163

  2049

  Downloads: 1422

• Pulmonary hypertension in autoimmune rheumatic diseases

  B. Marasini, M. Massarotti, R. Cossutta, L. Massironi, A. Mantero

  114-118

  https://doi.org/10.4081/reumatismo.2005.114

  1081

  Downloads: 2889